Open company graph database — free web & API
Login

Shenzhen Jincun Pharmaceutical Co., Ltd.

深圳津村薬業有限公司
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
12
§01

Basic information

BASIC
Head office
2-17-11 Akasaka, Minato-ku, Tokyo 107-8521, Japan
Chief executive
Terukazu Kato
Capital
30,142,000,000 JPY (301 100 millionJPY)
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

2
Prescription drug distributorOnline shop
§04

Related companies

12 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
LAO TSUMURA CO.,LTD.
Group
Shanghai Jincun Pharmaceutical Co., Ltd.
Group
TSUMURA USA, INC.
Group
Tianjin Jinmura Pharmaceutical Co., Ltd.
Group Supplier
Shengshi Baicao Pharmaceutical Co., Ltd.
Group Supplier
Logitem Tsumura Co., Ltd.
Group
Ping An Town Village Co., Ltd.
Group
Yubari Tsumura Co., Ltd.
Group
Tsutsumura (China) Co., Ltd.
Group
中国平安保険(集団)股分有限公司
Alliance
Ping An Tsunmura Pharmaceutical Co., Ltd.
Tsumura Co., Ltd.
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

8 EVENTS

The first-generation Shosha Tsumura, believing that “good medicine will always sell,” founded Tsumura Juntendo in Nihonbashi, Tokyo.Sources

From the company's founding to the end of the warSources

After the war, the second-generation Shosha, having been demobilized, once again put up the “Tsumura Juntendo” sign in the burned-out Nihonbashi district.Sources

Listing in the drug price schedule and diversification of the businessSources

Tsumura Juntendo's 33 Kampo formulations for medical use were listed in the National Health Insurance drug price standard and became available for use in medical practice as health insurance-covered medicines.Sources

Emerging from crisis and creating valueSources

At Tsumura, the company welcomed its first president from outside the company and began management reforms, including reducing interest-bearing debt and reorganizing subsidiaries.Sources

Management reforms began, including reducing interest-bearing debt and reorganizing subsidiaries.Sources

§07

News

9 ARTICLES

Project to Discuss Menstrual Concerns – Pop-Up EventSources

Tsumura Co., Ltd. will hold a pop-up event titled "Let's Find My PMS Signs" on December 4th and 5th at Tokyo Midtown Hibiya. With the support of the Japan Society of Gynecologists and the cooperation of Wellness Support Lab, individual booths staffed by nurses will be set up for direct consultations. The event aims to raise awareness by not overlooking the psychological symptoms of PMS and encouraging women to seek help from gynecology clinics.

IR News: 2026 Fiscal Year Q2 Earnings Presentation Script (including Q&A) ReleasedSources

IR News: 2026 Fiscal Year Q2 Earnings Presentation Script (including Q&A) Released

Tsumura Q2 FY 2027 Supplementary Financial StatementSources

This document is a supplementary financial statement for the second quarter (interim) of FY 2027. It contains the main financial statements, including the consolidated income statement, consolidated balance sheet, and consolidated cash‑flow statement. The impact of consolidating Yamaiyukijyusho Co., Ltd. from September 2026 is reflected, and the sales of that company are recorded under healthcare products.

IR News: 2026 Fiscal Year Q2 (Interim) Earnings Presentation ReleasedSources

Shenzhen Jincun Pharmaceutical Co., Ltd. has released the Q2 (interim) earnings presentation for fiscal year 2026. The presentation includes outlook toward the realization of the Long-Term Management Vision 2031 and revisions to the 2026 financial performance forecast.

Tsumura Kampo Series Teams Up with The Apothecary DiariesSources

Tsumura & Co. will launch a tie-in campaign for its over-the-counter Kampo medicines, the “Tsumura Kampo Series,” and “The Apothecary Diaries: The Lost Treasure of the Late Consort” on November 2, 2026. 1,000 people will be selected by lottery to receive an “Original Kampo START BOOK,” where they can learn about Kampo together with Maomao and the others.

Notice of Revision to Q2 and Full-Year Earnings Forecast for FY March 2027Sources

Shenzhen Jincun Pharmaceutical Co., Ltd. revised its consolidated earnings forecast for the second quarter and full year of the fiscal year ending March 2027. Revenue increased by 80 billion yen in domestic China and 220 billion yen overseas China, for a total revenue increase of 140 billion yen. Net profit increased by 100 billion yen, and earnings per share increased by 55.6%.

Notice of Temporary Suspension of Our ServiceSources

On October 22, 2026, a critical vulnerability was reported in the PHP used by our system, so we temporarily suspended part of the service as a security measure. At this time, no unauthorized access or data leaks have been confirmed. The suspension period is from October 22 until restoration. We apologize for any inconvenience and appreciate your understanding.

Release of Kyushu Menstrual Periods, PMS, and 'Hidden Endurance' SurveySources

#As part of the OneMoreChoice project, we surveyed 500 women aged 20-60 and 500 men of the same age group living in Kyushu who experience menstruation, regarding their awareness and reality of menstruation, PMS, and 'hidden endurance'. 67.6% of Kyushu residents reported experiencing 'hidden endurance', enduring the discomfort of menstruation/PMS while behaving normally. Of those whose discomfort affected daily life, 90.0% wanted others to understand that discomfort varies among individuals, while 68.7% felt it was difficult to convey their discomfort.

Tsumura Releases “A Promise of Quality,” a Video Series on Kampo Medicine QualitySources

On September 9, 2026, Tsumura released “A Promise of Quality,” a video series covering the process from cultivation and sourcing of crude drugs to medical practice. The 18 videos introduce each stage, alongside a one-minute digest and a CEO message, for 20 videos in total. The company also revamped its quality webpage.

§09

Sources & updates

SOURCES
↑